Effects of Salvianolate Injection on Myocardial Microcirculation Perfusion in Patients With Acute STEMI After Primary PCI (SISTEMI)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17010501

Enrollment

Unknown

Registered

2017-01-23

Start date

2017-01-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Interventions

Experimental group:Salvianolate injection

Control group:Normal saline

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Informed consent must be obtained prior to any study procedure; 2. Age>18 years; 3. Subjects of STEMI who underwent primary PCI within the first 12 hours.

Exclusion criteria

Exclusion criteria: 1. Allergic to Salvianolate injection; 2. Mechanical complications; 3. History of severe renal or hepatic insufficiency; 4. Pregnant or breastfeeding women; 5. Pool compliance,greater risks result from the study.

Design outcomes

Primary

Measure	Time frame
TFG and TMPG;	—

Secondary

Measure	Time frame
CTFC;CK-MB;MACE;	—

Countries

China

Contacts

Public ContactGe Junbo

Zhongshan Hospital Affiliated to Fudan University

yuyangxian021@163.com+86 21 64141990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026